Proven, Complementary Weight Loss Mechanism: CB1 Inhibition

Date published: July 9, 2025 9:00 pm PDT

Tu Diep, Tu Diep, explores Nimacimab’s CB1 inhibition which is proven to be peripherally targeted, drives fat mass loss and does not enter the brain. Nimacimab will fill a role that current drugs are not able to.